The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer December 2021 21(6):e731-e737 - Subject
- Language
- ISSN
- 1526-8209